Health Law Update

Home | Health Law Update

<strong><img class="alignright wp-image-5116 size-full" src="https://healthlawupdate.bakerhostetlerblogs.com/wp-content/uploads/sites/19/2019/05/1200x630Washington-DC-iStock_000074771283_Blog-image_lt-blue-e1549910644100.jpg" alt="" width="438" height="230" />UPDATE ON DRUG PRICING LEGISLATION AS CONGRESS RECONVENES</strong>

Congress reconvenes this week after a monthlong summer recess and begins what likely will be a final push toward overhauling prescription drug prices, but lack of consensus on the underlying policy and the intensifying 2020 presidential campaign will complicate efforts to advance a bill to President Donald Trump’s desk.

House Speaker <a href="https://www.speaker.gov/">Nancy Pelosi</a>, D-Calif., is <a href="https://www.axios.com/trump-nancy-pelosi-prescription-drug-prices-7896903c-f470-4516-867c-a5ecd1c6cc32.html">finalizing</a> long-awaited legislation centering on price negotiation for drugs that lack competition, and she could introduce legislation as soon as this week. But the <a href="https://thehill.com/homenews/house/447210-liberals-rip-democratic-leaders-for-writing-drug-pricing-bill-in-secret">secretive process</a> – even to most members of the Democratic Caucus – is <a href="https://news.bloomberglaw.com/health-law-and-business/too-little-too-late-pelosi-drug-pricing-plan-draws-skepticism">causing frustration</a>. Progressive lawmakers say the speaker’s plan <a href="https://cpc-grijalva.house.gov/uploads/8.28%20Pelosi%20Rx%20Pricing%20Letter%20with%20Signatures1.pdf">may not go far enough</a> on calling for government negotiation with manufacturers over prices.

<a href="https://www.ohioclock.com/2019/09/capitol-hill-healthcare-update-32/"><strong>Read more on BakerHostetler's Ohio Clock blog &gt;&gt;</strong></a>

Capitol Hill Healthcare Update